ID   OV202 hp
AC   CVCL_4068
SY   OV-202 hp; OV202 high passage
DR   Wikidata; Q54936885
RX   PubMed=10690552;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4067 ! OV202
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
RX   PubMed=10690552;
RA   Bible, Keith C.
RA   Boerner, Scott A.
RA   Kirkland, Kathryn
RA   Anderl, Kari L.
RA   Bartelt, Duane Jr.
RA   Svingen, Phyllis A.
RA   Kottke, Timothy J.
RA   Lee, Yean K.
RA   Eckdahl, Steven
RA   Stalboerger, Paul G.
RA   Jenkins, Robert Brian
RA   Kaufmann, Scott H.
RT   "Characterization of an ovarian carcinoma cell line resistant to
RT   cisplatin and flavopiridol.";
RL   Clin. Cancer Res. 6:661-670(2000).
//